GSK PLC (GSK)
40.86
-0.38
(-0.92%)
USD |
NYSE |
Apr 24, 16:00
41.38
+0.52
(+1.27%)
Pre-Market: 06:16
GSK Total Liabilities (Quarterly): 58.87B for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 58.87B |
| September 30, 2023 | 58.86B |
| June 30, 2023 | 59.66B |
| March 31, 2023 | 58.56B |
| December 31, 2022 | 60.57B |
| September 30, 2022 | 57.62B |
| June 30, 2022 | 80.54B |
| March 31, 2022 | 88.09B |
| December 31, 2021 | 77.96B |
| September 30, 2021 | 76.45B |
| June 30, 2021 | 76.72B |
| March 31, 2021 | 78.44B |
| December 31, 2020 | 81.26B |
| September 30, 2020 | 77.57B |
| June 30, 2020 | 79.40B |
| March 31, 2020 | 79.52B |
| December 31, 2019 | 80.42B |
| September 30, 2019 | 80.13B |
| June 30, 2019 | 76.88B |
| March 31, 2019 | 76.95B |
| December 31, 2018 | 69.02B |
| September 30, 2018 | 71.50B |
| June 30, 2018 | 71.40B |
| March 31, 2018 | 73.68B |
| December 31, 2017 | 71.48B |
| Date | Value |
|---|---|
| September 30, 2017 | 72.46B |
| June 30, 2017 | 70.01B |
| March 31, 2017 | 66.93B |
| December 31, 2016 | 66.48B |
| September 30, 2016 | 71.02B |
| June 30, 2016 | 71.89B |
| March 31, 2016 | 68.89B |
| December 31, 2015 | 66.03B |
| September 30, 2015 | 66.36B |
| June 30, 2015 | 68.51B |
| March 31, 2015 | 68.99B |
| December 31, 2014 | 55.59B |
| September 30, 2014 | 56.12B |
| June 30, 2014 | 54.53B |
| March 31, 2014 | 53.72B |
| December 31, 2013 | 56.52B |
| September 30, 2013 | 55.46B |
| June 30, 2013 | 53.07B |
| March 31, 2013 | 53.60B |
| December 31, 2012 | 56.15B |
| September 30, 2012 | 54.25B |
| June 30, 2012 | 53.78B |
| March 31, 2012 | 49.82B |
| December 31, 2011 | 49.70B |
| September 30, 2011 | 51.74B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
57.62B
Minimum
Sep 2022
88.09B
Maximum
Mar 2022
73.03B
Average
77.57B
Median
Sep 2020
Total Liabilities (Quarterly) Benchmarks
| AstraZeneca PLC | 61.95B |
| Haleon PLC | 22.07B |
| Novo Nordisk A/S | 30.87B |
| Pfizer Inc | 137.21B |
| Sanofi SA | 57.60B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 75.17B |
| Shareholders Equity (Quarterly) | 17.00B |
| Debt to Equity Ratio | 1.260 |
| Current Ratio | 0.8849 |
| Net Debt Paydown Yield | 0.87% |